Globally pharmaceuticals-related patents solely grew by a modest 2.7 p.c over a interval of 2009-2019 from 73,865 revealed functions in 2009 to 96,737 revealed functions in 2019. Nonetheless, nearly 17.8 per cent of the entire revealed functions from candidates residing in India have been into prescribed drugs from 2017.
“Amongst massive middle-income international locations throughout the identical interval (2017-2019), candidates residing in India (17.8% of whole revealed functions) and Mexico (10.5%) filed most closely in prescribed drugs. As information can be found solely up till 2019, it’s too early to watch the influence of the COVID-19 disaster on pharmaceutical patenting exercise,” mentioned the report.
Biotechnology grew 6.3 p.c through the decade, from 38,403 revealed functions in 2009 to 70,520 revealed functions in 2019, worldwide.
Apparently, the report says that worldwide, the fields of know-how associated to the lifesciences had comparatively excessive shares of Patent Cooperation Treaty (PCT) functions with girls inventors in 2020.
India has inched up two ranks to eighth by way of the very best variety of whole IP submitting exercise, together with resident and overseas filings, through the 12 months 2020, from the tenth place it had within the record through the 12 months 2018. In 2019, the nation was within the ninth rank, whereas China and the US continued to take care of their prime two ranks respectively in 2020.
“Ladies represented greater than one-quarter of inventors listed in revealed PCT functions within the discipline of biotechnology (29.5%), meals chemistry (29.4%), prescribed drugs (28.6%), evaluation of organic supplies (25.9%) and natural tremendous chemistry (25.2%),” it mentioned.
India has been ranked ninth by way of patents, sixth by way of commerce marks and thirteenth by way of designs, within the 12 months 2020, contemplating each resident and overseas IP submitting. The rank record is led by China, adopted by the US, Germany, Japan, Republic of Korea, France and the UK. When it comes to resident IP exercise, throughout 2020, India ranked seventh.
“India has round 615 patent examiners with a median expertise of 4.5 years, whereas China has the very best numbers at 13,704 examiners adopted by the US (8,132). Common pendency time for the ultimate choice of an utility in India is round 42 months, whereas China and US have 20 months and 20.8 months, respectively. The primary workplace motion following a patent submitting in India is taken in a median interval of 18 months from submitting,” report added.